Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
Auto-generated profile, based on publicly available information
Nadezhda N. Trubnikova
Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia
Molecular modelling of the structure and evaluation of the chemical shifts of 1H and 13C nuclei were performed for the 4-[4-(2-aminoethoxy)benzyl]aniline, which is a structural analogue of thyronamines. The intramolecular dynamics of the key structural fragments of 4-[4-(2-aminoethoxy)benzyl]aniline were studied by the PM6-DH2 method as well as at the B3LYP/6-31G(d,p) level of theory. Nonspecific solvation with dimethyl sulfoxide was taken into account within the polarized continuum model. Specific solvation by one and two DMSO molecules was considered within supermolecule approximation. Chemical shifts of the 1H and 13C nuclei were estimated for the most stable conformer of 4-[4-(2-aminoethoxy)benzyl]aniline as well as for its solvates with DMSO. Calculated chemical shifts of the 1H and 13C nuclei are in good agreement with the experimental ones obtained for 4-[4-(2-aminoethoxy)benzyl]aniline in DMSO-d6 solution. Some aspects of the bioactivity of 4-[4-(2-aminoethoxy)benzyl]aniline are discussed.
Experimental and molecular modelling data on chemical shifts of 1H and 13C nuclei are presented for the 4-[4-(2-aminoethoxy)phenoxy]aniline (APA) dihydrochloride, which is a new structural analogue of thyronamine T0AM. In our study we treat two structural models of the APA—its protonated form [H-APA-H]2+ and neutral dihydrochloride APA·2HCl. Chemical shifts in the 1H and 13C nuclei were estimated for the basic conformers of [H-APA-H]2+ and APA·2HCl models. Nonspecific solvation with DMSO was taken into account within the polarized continuum model. Calculated chemical shifts in the 1H and 13C nuclei were in good agreement with the experimental ones obtained for 4-[4-(2-aminoethoxy)phenoxy]aniline dihydrochloride in DMSO-d6 solution.
The release of reactive oxygen species accompanying oxidative stress is one of the most significant damaging mechanisms during brain ischemia. Some aspects of the neuroprotective activity of the thyronamine T0AM synthetic analogue, 4-[4-(2-aminoethoxy)benzyl]aniline (ABA), were studied and discussed in two independent experiments using a model of acute cerebral ischemia. Antioxidant effects were evaluated in adult male and female Wistar rats (Rattus norvegicus), while neurological outcomes were assessed in adult male outbred white rats. Administration of the ABA in a rat brain hemisphere ischemia model was associated with significant changes in redox markers: malondialdehyde, glutathione peroxidase and superoxide dismutase levels in the ischemic hemisphere. Also, the introduction of ABA into the model of acute cerebral ischemia contributed to a reduction in neurological deficit compared to untreated controls. It was revealed that the considered thyronamine T0AM analogue could control redox status in acute brain ischemia. Mono protonated form of ABA (ABA-H+) is considered to be the main species at pH 6.9–7.2. Structural models of the neutral (ABA), protonated (ABA-H+) thyronamine and its solvate (DMSO…ABA-H+) were used in DFT calculations, followed by estimation of molecular and supramolecular level descriptors.